PCM Trials is now EmVenio Clinical Research! We’re uniting with CTS & EmVenio Research to with a renewed commitment to expanding access, build trust, and deliver data that reflects the real world. Follow @EmVenio for what’s next.
#ResultsForYou#ScienceForAll#EmVenioImpact
Happy #WorldHealthDay! This year focuses on maternal & newborn health. Community-based research models enable trial participation from even the most vulnerable populations to support healthy beginnings and hopeful futures for all! #HealthEquity#MaternalHealth#NewbornHealth
How do community-based research sites expand access to trials while ensuring consistency in study protocols? Dr. Mark McKenzie explains that these sites bring trials to local communities while maintaining rigorous trial standards. Learn more: https://t.co/fFAPaLcRPb
We're excited to meet up with our European research community at DIA EU 2025. Stop by to meet our team & learn more about the ways we're reaching and retaining more patients in clinical trials around the world
#CommuityResearch#InnovationInHealthcare#PatientAccess#GlobalReach
Access is everything in #clinicalresearch. More women, African Americans, and Native Americans enroll in trials when community-based options are available. Tajuana Barron explains how flexible participation bridges access gaps. Learn more: https://t.co/UMEHFcUkYW
#AccessForAll
Kicking off the day at #SCOPE2025 with great discussions & new connections! Stop by booth #1428 to receive a free health check from one of our attending providers, meet our team, and learn more about how community-based research solutions can extend the reach of clinical trials.
The push for diverse representation in clinical trials is gaining momentum. Tajuana Barron, VP of Project Management at PCM Trials, shares why diverse participation is essential for safe, effective treatments. Learn more about efforts driving diversity: https://t.co/p0tYwq9soJ
We’re thrilled to attend #SCOPE2025 with EmVenio Research, Feb 3-6! Connect with our team or get a health check from one of our attending providers at booth #1430. Don't miss our session Feb 4 at 1:05 PM. See you in Orlando! 🌴 #ClinicalTrials#HealthEquity#CommunityResearch
#HappyHolidays from PCM Trials!❄️ We grew tremendously in 2024, enabling us to reach more patients and communities than ever before. We are deeply grateful for all of the clinicians, partners, and participants who have been a part of our journey. Here's to a prosperous new year!
In our latest webinar, we explored FDA guidance on diversity in clinical trials, emphasizing the critical role of diversity action plans in improving enrollment and retention of underrepresented populations. Watch the webinar or read more: https://t.co/WMLAkg2FO8 #AccessForAll
#NationalAlzheimersAwarenessMonth With 6.9M Americans 65+ living with Alzheimer’s, and nearly 13M projected by 2050, addressing their needs is critical. Learn more about how mobile visits make trials more accessible for those affected by Alzheimer's here: https://t.co/9mRnxYWCre
At #DIA2024, Jon Ernst, VP of In-Home Solutions, discussed how PCM Trials and @EmvenioResearch are bridging gaps in clinical trial access. Through mobile visits and community-based research, we're creating a seamless, patient-centered journey. Learn more: https://t.co/FoyidxwD42
At OCT SoCal, Rachael Sawaya tackled a key issue: bridging the gap between healthcare desserts & clinical trial access. Community-based models bring trials to rural areas, helping reach traditionally underrepresented populations. Learn more: https://t.co/qnXguEqRUC #AccessForAll
We are excited to attend #CNSSummit in Boston, Nov 10-13!
Meet Jonathan and Jeff at booth #309 to learn how PCM Trials and EmVenio Research's community research model is boosting trial outcomes and access for underrepresented populations.
#ClinicalTrials#CommunityResearch
Many trial sponsors find mobile visits crucial for meeting enrollment and diversity goals. Tajuana Barron shares how consistent clinician interactions build trust and engagement. Learn how this aligns with recent FDA guidance on inclusive trials here https://t.co/rSfw30h04l
Convenient clinical trial access under PI guidance helps studies finish on time and boosts diverse recruitment by reducing barriers. Dr. Rohit Aggarwal from the Univ. of Pittsburgh discusses mobile visits in an interstitial lung disease study. Watch here: https://t.co/ZgLq7twkqe
Today is #WorldCancerResearchDay! At PCM Trials, we bring cancer trials directly to participants, because everyone should have the opportunity to participate in life-changing research. Thank you to all in cancer research for your tireless efforts!
#CancerResearch#AccessForAll